BAX and nonpapillary renal cell carcinoma: Further mechanistic studies are warranted to investigate whether BAX-mediated ammonia-related cell death is modulated by or intersects with other cell death programs, which could reveal novel combinatorial therapeutic strategies targeting multi-modal vulnerabilities in ccRCC.